Nuvectis Pharma
NVCT
NVCT
8 hedge funds and large institutions have $4.65M invested in Nuvectis Pharma in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+8
Holders Change %
–
% of All Funds
0.13%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
8
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RC
Ronit Capital
London,
United Kingdom
|
+$4.08M |
| 2 |
Millennium Management
New York
|
+$312K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$109K |
| 4 |
VF
Virtu Financial
New York
|
+$84K |
| 5 |
BlackRock
New York
|
+$59K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
RC
1
Ronit Capital
London,
United Kingdom
| $4.08M | +$4.08M | +550,000 | New |
|
|
2
Millennium Management
New York
| $312K | +$312K | +42,160 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $109K | +$109K | +14,822 | New |
|
|
VF
4
Virtu Financial
New York
| $84K | +$84K | +11,365 | New |
|
|
5
BlackRock
New York
| $59K | +$59K | +7,872 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $13K | +$13K | +1,750 | New |
|
7
UBS Group
Zurich,
Switzerland
| $1K | +$1K | +141 | New |
|